Physician profile
Brian Cronin
NPI 1679992382
$10,700.49
in general payments reported to CMS, 2019-2025
22 companies · $2,750 in 2025
The $2,750 reported for 2025 was more than what 76% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.04 · 2020: $3,730 · 2021: $226 · 2022: $2,431 · 2023: $778 · 2024: $715 · 2025: $2,750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,242.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $3,730.18 | 2020 | |
| Silk Road Medical, INC. | $1,831.40 | 2022-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Stryker Corporation | $1,708.58 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Clottriever Bold Catheter |
| Inari Medical, INC. | $885.05 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $648.39 | 2021-2025 | Endurant Iis, Abre, In.Pact Admiral |
| Philips North America LLC | $382.30 | 2025 | Phoenix, Technical Education Mri |
| Janssen Pharmaceuticals, INC | $269.04 | 2022-2023 | Xarelto |
| Penumbra, INC. | $224.87 | 2025 | Penumbra System |
| Bard Peripheral Vascular, INC. | $140.92 | 2021-2022 | |
| Endologix LLC | $126.37 | 2023 | Alto Abdominal Stent Graft System |
| Lemaitre Vascular, INC. | $112.17 | 2023-2024 | Artegraft Vascular Graft, Restoreflow |
| Janssen Scientific Affairs, LLC | $102.80 | 2022 | |
| Shockwave Medical, INC | $96.88 | 2022 | |
| Smith+Nephew, INC. | $87.96 | 2021-2023 | Grafix Pl, Oasis, Grafix |
| Glaxosmithkline, LLC. | $72.97 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $71.04 | 2019 | |
| W. L. Gore & Associates, INC. | $70.89 | 2025 | Gore Excluder Iliac Branch Endoprosthesis |
| Baxter Healthcare | $46.73 | 2021-2022 | |
| Mozarc Medical US LLC | $29.42 | 2023 | Palindrome |
| Cook Medical LLC | $25.20 | 2023 | Zenith |
| Integra Lifesciences Corporation | $19.48 | 2023 | Integra, Omnigraft, Surgimend |
| Lilly USA, LLC | $17.85 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Cronin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.